10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,913 | -26.3% | 410 | -0.2% | 0.00% | 0.0% |
| Q2 2023 | $22,950 | +3.9% | 411 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $22,093 | +53.1% | 396 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $14,430 | +11.0% | 396 | -16.3% | 0.00% | 0.0% |
| Q3 2022 | $13,000 | -38.1% | 473 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21,000 | +10.5% | 473 | +85.5% | 0.00% | 0.0% |
| Q1 2022 | $19,000 | -50.0% | 255 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $38,000 | -20.8% | 255 | -23.2% | 0.00% | -66.7% |
| Q3 2021 | $48,000 | -26.2% | 332 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $65,000 | – | 332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |